A Safe Bet Against a global health threat

Marc has extensive experience in both academia and industry, having worked more than 20 years in R&D in the chemical and life-sciences. He holds a BSc from the University of Durham and a PhD in medical biochemistry from the University of Cambridge, UK. He was co-founder, Chief Scientific Officer and inventor of granted patents at a biotech startup company in the UK, where he learned the challenges and opportunities of entrepreneurship. Marc is also active in Swiss science policy as a member of the Board of Platform Biology of the Swiss Academy of Sciences (SCNAT), the Board of the Swiss Antibiotics Roundtable and President of the Advisory Board of the Swiss Young Academy, where his interests lie on role of innovation in the life sciences, science-communication and technology transfer.

‍